1. A case with anti-GPIHBP1 antibody positive autoimmune hyperchylomicronemia accompanied with idiopathic thrombocytopenic purpura. (August 2021) Authors: Tanaka, K.; Koseki, M.; Kato, H.; Chang, J.; Okada, T.; Inui, H.; Zhu, Y.; Ohama, T.; Nishida, M.; Miyashita, K.; Yamashita, S.; Sakata, Y. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case with sitosterolemia accompanied with macrothrombocytopenia and bilateral elbow tuberous xanthomas. (August 2021) Authors: Okada, T.; Koseki, M.; Kato, H.; Tomita, K.; Tanaka, K.; Chang, J.; Inui, H.; Kanno, K.; Saga, A.; Ohama, T.; Kujiraoka, T.; Hattori, H.; Nishida, M.; Yamashita, S.; Sakata, Y. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Diet-induced hepatic steatosis and fibrosis were improved by a selective ppara modulator, pemafibrate, in STZ -induced diabetic mice. (August 2021) Authors: Chang, J.; Koseki, M.; Kanno, K.; Saga, A.; Okada, T.; Tanaka, K.; Kamada, Y.; Higo, T.; Okuzaki, D.; Inui, H.; Asaji, M.; Zhu, Y.; Ohama, T.; Nishida, M.; Yamashita, S.; Sakata, Y. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DPP4 inhibitor, anagliptin, ameliorates fasting and postprandial hypertriglyceridemia. (September 2016) Authors: Sairyo, M.; Masuda, D.; Kobayashi, T.; Matsuda, H.; Okada, T.; Kawase, R.; Nakatani, K.; Koseki, M.; Ohama, T.; Nishida, M.; Sakata, Y.; Yamashita, S. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. High-performance gel permeation chromatography analysis demonstrates atherogenic properties of lipoproteins in patients with cholesteryl ester transfer protein deficiency. (September 2016) Authors: Okada, T.; Ohama, T.; Okazaki, M.; Matsuda, H.; Sairyo, M.; Zhu, Y.; Kawase, R.; Masuda, D.; Koseki, M.; Nishida, M.; Sakata, Y.; Yamashita, S. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunometabolic disorder in cardiovascular system and liver mediated by long-term exposure to diet-derived oxidized cholesterol, 7-ketocholesterol. (December 2020) Authors: Koseki, M.; Kanno, K.; Saga, A.; Chang, J.; Inui, H.; Okada, T.; Ohama, T.; Nishida, M.; Kamada, Y.; Miyoshi, E.; Yamashita, S.; Sakata, Y. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prevalence of coronary artery disease and achievement of low-density lipoprotein cholesterol management targets in familial hypercholesterolemia patients at Osaka University Hospital. (December 2020) Authors: Okada, T.; Koseki, M.; Inui, H.; Kanno, K.; Saga, A.; Ohama, T.; Nishida, M.; Yamashita, S.; Sakata, Y. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗